A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

NCT00487188 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Enfuvirtide
DRUG: Highly active antiretroviral treatment (HAART)

Sponsor

Hoffmann-La Roche